About Bio Rad
Bio Rad is a publicly listed company based in Hercules (United States) founded in 1952. Portfolio of products and services for life science research and clinical diagnostic markets. The company has 7,700 employees. Bio Rad has completed 8 acquisitions, including Abd Serotec, Celsee Diagnostics and Dropworks. Its website bio-rad.com draws about 665 thousand monthly visits. Its focus areas include Life Sciences, Life Sciences Platforms and Tools and Diversified. Its legal entity is Bio-Rad Denmark ApS. Its competitors include Quanterix, Biocare Medical and BioLife Solutions; 2 of its 3 listed competitors have raised funding.
Company details
Bio-Rad was founded in 1952 and is headquartered in Hercules, United States. Operations focus on the biotechnology and healthcare sectors, where a variety of productsincluding reagents, instruments, software, and apparatusare developed for laboratory applications. These support drug discovery, functional genomics, proteomics, food pathogen testing, and studies of biological processes. Services extend to clinical diagnostics, with emphasis on research tools used globally in scientific and medical settings.
- Headquarters Hercules, United States
- Employees 7,700
- Stage Public
- SectorsHealthcare
- Website category Science and Education · Biology
- Email••••••••
- Website bio-rad.com
- Social LinkedIn X Facebook
- Legal Name Bio-Rad Laboratories, Inc.
- Annual Revenue$2.58 B (USD)0.65as on Dec 31, 2025
- Net Profit$759.9 M (USD)as on Dec 31, 2025
- EBITDA$471.5 M (USD)-6.41as on Dec 31, 2025
- Latest Funding Round$66.88K (USD), Grant
Dec 2021
- InvestorsHHS
& 2 more
- Employee Count7,700
- Investments & AcquisitionsAbd Serotec
& 7 more
Funding Insights of Bio Rad
- Total Rounds 14
- Last Round Grant — $66,875
- First Round $225M
(Aug 2003)
- Investors Count 3
Latest 10 of 14 funding rounds of Bio Rad with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2021 | $66,875 | Grant | – | – | |
| Dec 2020 | $26,982 | Grant | – | – | |
| Dec 2019 | $32,824 | Grant | – | – | |
| Dec 2019 | $19,683 | Grant | – | – | |
| Nov 2019 | $82,211 | Grant | – | – | |
| Jul 2019 | $203,949 | Grant | – | – | |
| Jan 2019 | $230,647 | Grant | – | – | – |
| Aug 2017 | $76,754 | Grant | – | – | |
| Nov 2016 | $69,936 | Grant | – | – | |
| Jun 2015 | Grant | – | – |
3 investors in total: 3 institutional.
Investors in Bio Rad
Bio Rad has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include HHS, European Union and Military Health.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium | |
Public health and human services are overseen by HHS. | 1953 | hhs.gov | ||
| health.mil |
Investor details for Bio Rad
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Bio Rad
520 people are tracked at Bio Rad (138 in leadership, 5 in board & advisors, 377 in team); the tracked headcount is 7,700.
| Name | Role | Group |
|---|---|---|
Noel Alberola | European Life Sciences Group Director | Leadership |
Norman Schwartz | Chairman, President & CEO | Leadership |
Paulette Johansen | Director, Global Hr, Corp Services & Staffing | Leadership |
Melissa Eng | Sr Director, Global Human Resources, CDG And LSG | Leadership |
Sarah Bialas | Director, Product Quality | Leadership |
Bence István Egri | Finance Business Partner Team Leader | Leadership |
Jim Smith | Senior Talent Acquisition Partner | Leadership |
Diane Galea | Director, EMEA Product Quality Assurance | Leadership |
Karen Davis-Fleischer | Vice President, Global Strategic Marketing, Core Diagnostics Business Segment | Leadership |
Elisa Barrett | Associate Director, Marketing, Autoimmune | Leadership |
Anthony Boyle | Associate Director Core Team Leader | Leadership |
Abdelrahman Abushehab | Managing Director At Bio-rad Regional Headquarters Saudi. Regional Sales Manager Eemea | Leadership |
Greg Annas | Vice President, Commercial Operations, Asia Pacific | Leadership |
Malisa Sangsiripisal | Associate Director, Downstream Marketing - Molecular Diagnostics | Leadership |
Nicola Zahl | Vice President Global Strategic Marketing, Quality Systems | Leadership |
Heather Treptow | Director, Commercial Effectiveness, Global Commercial Operations | Leadership |
Elisabeth Klein | Head Of Revenue Operations EMEA | Leadership |
Franklin Boekhorst | Associate Director Sales, EMEA Process Chromatography | Leadership |
Rajat Mehta | Executive Vice President, Global Commercial Operations | Leadership |
Christopher Lee | Associate Director | Leadership |
500 more people are available in the full profile.
Complete people profiles for Bio Rad
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Bio Rad
Bio Rad is a publicly listed company on the NYSE with ticker symbol BIO in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date11 Oct 1999
- Listed onNYSE: BIO.B
- Listed entityBio-Rad Laboratories, Inc.
- Exchange sectorHealth technology
- ISINUS0905722072
- Share price$363.73 (-0.19% on the day) · 2026-10-13
- Market capitalisation$9.78B
- Price to earnings44.1
- EPS (diluted, trailing year)$8.25
- Volume (last session)132,592
Financials of Bio Rad
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | $2.58B | $759.9M | $471.5M |
| 2024 | $2.57B | -$1.84B | $503.8M |
| 2023 | $2.67B | -$637.3M | $576.2M |
| 2022 | $2.80B | -$3.63B | $656.5M |
| 2021 | $2.92B | $4.25B | $741.6M |
Detailed financial statements for Bio Rad
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Bio Rad
Bio Rad has strategically engaged in corporate development activities, having acquired 8 companies. Notable acquisitions include Abd Serotec, Celsee Diagnostics and Dropworks.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Digital PCR solutions for research are developed and analyzed. | stillatechnologies.com | Villejuif, France | 2013 | Feb 2025 | •••• | |
PCR diagnostic kits are manufactured by PCR|ONE for medical use. | pcrone.com | Warsaw, Poland | 2019 | Aug 2022 | •••• | |
Digital PCR instruments are manufactured for laboratory use. | dropworks.com | Phoenix, United States | 2016 | Oct 2021 | •••• | |
Liquid biopsy technology for monitoring circulating tumor cells is provided. | celsee.com | Plymouth, United States | 2011 | Apr 2020 | •••• | |
Developer of nucleic acid detection and quantification systems | raindancetech.com | Billerica, United States | 2004 | Jan 2017 | •••• | |
DNA sequencing platform using microfluidic technology is developed for diagnostics. | gnubio.com | Cambridge, United States | 2009 | Apr 2014 | •••• | |
Antibodies, kits, and reagents are manufactured and supplied globally. | abdserotec.com | Raleigh, United States | 1980 | Dec 2012 | $69.27M | |
Provide tools that accelerate new strategies for the diagnosis and treatment of inherited disorders, cancer, and infectious disease. | quantalife.com | Pleasanton, United States | 2008 | Oct 2011 | $162M |
Complete acquisition details for Bio Rad
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Bio Rad
12 dated milestones of Bio Rad across 73 years, from founding to its latest funding, stage changes and deals.
- Founded Bio Rad is founded.
- IPO Lists on the stock exchange (IPO).
- Funding First funding round of $225.0M.
- Acquisition Acquires Quantalife.
- Acquisition Acquires Abd Serotec.
- Acquisition Acquires GnuBIO.
- Acquisition Acquires RainDance.
- Acquisition Acquires Celsee Diagnostics.
- Acquisition Acquires Dropworks.
- Funding Latest funding round, Grant, of $67K.
- Acquisition Acquires PCR|ONE.
- Acquisition Acquires Stilla Technologies.
Competitors of Bio Rad
Bio Rad has 3 listed competitors in our database, 2 of them funded. They include Quanterix, Biocare Medical and BioLife Solutions.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| quanterix.com | 2007 | Cambridge, United States | $99.5M | 141 | Assay kits for ultra-sensitive biomarker detection are developed. | |
| biocare.net | 1997 | Concord, United States | $85M | 161 | Primary antibodies and instruments for immunohistochemistry are manufactured. | |
| biolifesolutions.com | 1987 | Bothell, United States | 685 | Tissue hypothermic storage and cryopreservation freeze media are developed. |
Detailed competitors of Bio Rad
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Bio Rad
The website of Bio Rad (bio-rad.com) receives about 665.2K visits a month and ranks #79,666 among all websites worldwide, #5,048 in Biology.
- Monthly visits665.2K
▲ 8.2% vs previous month
- Unique visitors284.5K
per month
- Global rank#79,666
among all websites
- Category rank#5,048
Science and Education · Biology
- Bounce rate48%
- Pages per visit3.0
- Average visit1 min 58 sec
- DevicesDesktop 59% · Mobile 41%
Websites whose visitors overlap most with Bio Rad. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| neb.com | 100% | 749.5K | #69,042 | View details | |
| qiagen.com | 98% | 458.2K | #105,023 | View details | |
| abcam.com | 86% | 602.8K | #91,958 | View details | |
| invitrogen.com | 72% | 5.2K | #3,688,642 | View details | |
gelifesciences.com | gelifesciences.com | 71% | – | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for Bio Rad
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Bio Rad (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Bio Rad
Complete news archive for Bio Rad
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bio Rad
Bio Rad was founded in 1952 and raised its 1st funding round 51 years after it was founded.
Bio Rad is headquartered in Hercules, United States. It is registered at Hercules, California, United States.
Bio Rad has 7,700 employees.
Annual revenue of Bio Rad is $2.58B as on Dec 31, 2025.
Bio-Rad was founded in 1952 and is headquartered in Hercules, United States. Operations focus on the biotechnology and healthcare sectors, where a variety of productsincluding reagents, instruments, software, and apparatusare developed for laboratory applications. These support drug discovery, functional genomics, proteomics, food pathogen testing, and studies of biological processes. Services extend to clinical diagnostics, with emphasis on research tools used globally in scientific and medical settings.
Bio Rad's top competitors include Biocare Medical, Quanterix and BioLife Solutions.
Yes, Bio Rad is publicly traded on NYSE under the ticker symbol BIO.
Bio Rad has made 8 acquisitions, including Abd Serotec, Celsee Diagnostics, and Dropworks.
Bio Rad has 3 investors. Key investors include HHS, European Union, and Military Health.
Bio Rad operates through Bio-Rad Denmark Aps.
The website of Bio Rad receives about 665 thousand visits a month and ranks #79,666 among all websites worldwide.